Lipopeptide stabilized microbubbles as diagnostic/therapeutic agents
US6548048B1 · kind B1 · utility
44Cited by
5References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2000 |
| Grant date | Apr 15, 2003 |
| Priority date | — |
| Expiry date | Oct 25, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/93
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel membrane-forming amphiphilic lipopeptides comprising one or more peptide moieties containing 2-50 aminoacyl residues and one or more hydrocarbon chains containing 5-50 carbon atoms. Such lipopeptides may be used in the formation of stabilized gas microbubble dispersions suitable for use as diagnostic and/or therapeutic agents, for example as ultrasound contrast agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.